These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35737650)

  • 1. Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses.
    Pan J; Bunn V; Hupf B; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):613-626. PubMed ID: 35737650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints.
    Chen N; Lee JJ
    Stat Methods Med Res; 2020 Sep; 29(9):2717-2732. PubMed ID: 32178585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating external data into the analysis of clinical trials via Bayesian additive regression trees.
    Zhou T; Ji Y
    Stat Med; 2021 Dec; 40(28):6421-6442. PubMed ID: 34494288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric failure time: Time-to-event machine learning with heteroskedastic Bayesian additive regression trees and low information omnibus Dirichlet process mixtures.
    Sparapani RA; Logan BR; Maiers MJ; Laud PW; McCulloch RE
    Biometrics; 2023 Dec; 79(4):3023-3037. PubMed ID: 36932826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.
    Jin J; Riviere MK; Luo X; Dong Y
    Stat Med; 2020 Nov; 39(25):3459-3475. PubMed ID: 32717103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
    Zhang J; Lin R; Chen X; Yan F
    Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian additive regression trees and the General BART model.
    Tan YV; Roy J
    Stat Med; 2019 Nov; 38(25):5048-5069. PubMed ID: 31460678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borrowing information across subgroups in phase II trials: is it useful?
    Freidlin B; Korn EL
    Clin Cancer Res; 2013 Mar; 19(6):1326-34. PubMed ID: 23303215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial.
    Turner RM; Turkova A; Moore CL; Bamford A; Archary M; Barlow-Mosha LN; Cotton MF; Cressey TR; Kaudha E; Lugemwa A; Lyall H; Mujuru HA; Mulenga V; Musiime V; Rojo P; Tudor-Williams G; Welch SB; Gibb DM; Ford D; White IR;
    BMC Med Res Methodol; 2022 Feb; 22(1):49. PubMed ID: 35184739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers.
    Takeda K; Liu S; Rong A
    Stat Med; 2022 Jan; 41(2):298-309. PubMed ID: 34697822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing.
    Best N; Price RG; Pouliquen IJ; Keene ON
    Pharm Stat; 2021 May; 20(3):551-562. PubMed ID: 33475231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian additive regression trees for multivariate skewed responses.
    Um S; Linero AR; Sinha D; Bandyopadhyay D
    Stat Med; 2023 Feb; 42(3):246-263. PubMed ID: 36433639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees.
    Logan BR; Sparapani R; McCulloch RE; Laud PW
    Stat Methods Med Res; 2019 Apr; 28(4):1079-1093. PubMed ID: 29254443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian sample size determination in basket trials borrowing information between subsets.
    Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
    Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flexible approach for variable selection in large-scale healthcare database studies with missing covariate and outcome data.
    Lin JJ; Hu L; Huang C; Jiayi J; Lawrence S; Govindarajulu U
    BMC Med Res Methodol; 2022 May; 22(1):132. PubMed ID: 35508974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level data.
    Hupf B; Yang Y; Gryder R; Bunn V; Lin J
    J Biopharm Stat; 2024 Oct; 34(6):944-952. PubMed ID: 38562017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage subgroup-specific time-to-event (2S-Sub-TITE): An adaptive two-stage time-to-toxicity design for subgroup-specific dose finding in phase I oncology trials.
    McGovern A; Chapple AG; Ma C
    Pharm Stat; 2022 Nov; 21(6):1138-1148. PubMed ID: 35560864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.